Skip to main content
. 2018 May 22;9(6):591. doi: 10.1038/s41419-018-0645-3

Fig. 7. PF inhibited colorectal cancer growth in vivo.

Fig. 7

a Images of SW480 tumour-bearing mice after treated with PF (10 and 20 mg/kg) or oxaliplatin (5 mg/kg). b–e SW480 tumour-bearing mice were treated with PF (10 and 20 mg/kg) or oxaliplatin (5 mg/kg) for four weeks. Morphology of tumour (b), changes of tumour weight (c), tumour volume (d), and body weight (e) were shown. Data represent the means ± SD (n = 6), **P < 0.01, compared with control group. f Images of spleen in mice after administration of PF (10 and 20 mg/kg) or oxaliplatin (5 mg/kg) for four weeks. g The spleen index was calculated as spleen weight/body weight. Data represent the means ± SD (n = 6), *P < 0.05, **P < 0.01, compared with control group